推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

CURRENT PHARMACEUTICAL DESIGN

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 CURR PHARM DESI最新评论:您好,投出去大概多长时间送的外审啊 (2023-12-05)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
 
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


CURRENT PHARMACEUTICAL DESIGN期刊基本信息Hello,您是该期刊的第92942位访客


基本信息 登录收藏
期刊名字CURRENT PHARMACEUTICAL DESIGNCURRENT PHARMACEUTICAL DESIGN

CURR PHARM DESIGN
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
5.7
53人评分
我要评分

声誉
6.4

影响力
4.4

速度
8.5

期刊ISSN1381-6128
微信扫码收藏此期刊
E-ISSN1873-4286
2023-2024最新影响因子
(数据来源于搜索引擎)
2.6 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日:2.056
2023-2024自引率3.80%点击查看自引率趋势图
五年影响因子3
JCI期刊引文指标 0.48
h-index 140
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
6.300.5860.625
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q2107 / 313
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Drug Discovery
Q262 / 157

期刊简介
Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.
期刊官方网站http://benthamscience.com/journal/index.php?journalID=cpd
期刊投稿网址http://benthamscience.com/journal/authors-guidelines.php?journalID=cpd#top
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CURRENT PHARMACEUTICAL DESIGN的语言要求,还能让CURRENT PHARMACEUTICAL DESIGN编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CURRENT PHARMACEUTICAL DESIGN编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR
出版商Bentham Science Publishers B.V.
涉及的研究方向医学-药学
出版国家或地区NETHERLANDS
出版语言English
出版周期Biweekly
出版年份1995
年文章数 276点击查看年文章数趋势图
Gold OA文章占比1.34%
研究类文章占比:
文章 ÷(文章 + 综述)
35.87%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:2区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:PHARMACOLOGY & PHARMACYSCIEQ2173/354
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:PHARMACOLOGY & PHARMACYSCIEQ3247/354
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 1区4区4区
PHARMACOLOGY & PHARMACY
药学
4区3区4区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 1区4区1区
PHARMACOLOGY & PHARMACY
药学
1区4区4区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 2区4区1区
PHARMACOLOGY & PHARMACY
药学
3区2区4区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1381-6128%5BISSN%5D
平均审稿速度网友分享经验:
平均2月
平均录用比例网友分享经验:
约25%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在CURRENT PHARMACEUTICAL DESIGN顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 CURRENT PHARMACEUTICAL DESIGN期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CURRENT PHARMACEUTICAL DESIGN中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CURRENT PHARMACEUTICAL DESIGN上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    PHARMACOLOGICAL REVIEWS21034.70
    DRUG RESISTANCE UPDATES10026.20
    ADVANCED DRUG DELIVERY REVIEWS27828.10
    TRENDS IN PHARMACOLOGICAL SCIENCES20123.90
    PHARMACOLOGY & THERAPEUTICS18023.00
    MEDICINAL RESEARCH REVIEWS11929.30
    PHARMACOLOGICAL RESEARCH11818.70
    ARCHIVES OF PHARMACAL RESEARCH7513.40
    BIOMEDICINE & PHARMACOTHERAPY7811.90
    BRITISH JOURNAL OF PHARMACOLOGY19015.40
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE677700
    BIOMATERIALS567285
    BIOMEDICINE & PHARMACOTHERAPY552018
    Frontiers in Pharmacology515786
    Journal of Materials Chemistry B506974
    Frontiers in Immunology492571
    COMPUTERS IN BIOLOGY AND MEDICINE474436
    JOURNAL OF ETHNOPHARMACOLOGY466711
    COLLOIDS AND SURFACES B-BIOINTERFACES438831
    Frontiers in Oncology436521
  •  

    CURRENT PHARMACEUTICAL DESIGN CURRENT PHARMACEUTICAL DESIGN
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Use of Novel m6A Regulator-mediated Methylation Modification Patterns in Distinct Tumor Microenvironment Profiles to Identify and Predict Glioma Prognosis and Progression, T-cell Dysfunction, and Clinical Response to ICI Immunotherapy

    Author: Zhao, Binghao; Xiang, Zhongtian; Wu, Bo; Zhang, Xiang; Feng, Nan; Wei, Yiping; Zhang, Wenxiong
    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 1, pp. 60-78. DOI: 10.2174/1381612829666221207112438
        PubMed      DOI
    2.Exploration and Practice of Medicine Pathway for Perioperative VTE Prophylactic Anticoagulant Treatment

    Author: Zhang, Bin; Zhang, Chuanzhou; Li, Yongxin; Zhou, Changkai; Shi, Shiqiang; Ji, Hongyan; Li, Jing
    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 4, pp. 251-255. DOI: 10.2174/1381612829666230112165449
        PubMed      DOI
    3.Scutellarin Suppressed Proliferation and Induced Apoptosis in Gastric Cancer via Wnt/beta-catenin Signaling Pathway

    Author: Wang, Zhenkai; Liu, Xiang; Chen, Wanzhen; Guo, Xiujun; Chen, Lili; Wei, Zhiqin; Liu, Dan; Liu, Zheng
    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 5, pp. 368-378. DOI: 10.2174/1381612829666230130141931
        PubMed      DOI
    4.Network Pharmacology and Integrated Molecular Docking Study on the Mechanism of the Therapeutic Effect of Fangfeng Decoction in Osteoarthritis

    Author: Wang, Wenqiao; Li, Min; Si, Hongzong; Jiang, Zehui
    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 5, pp. 379-392. DOI: 10.2174/1381612829666230216095659
        PubMed      DOI
    5.Isorhynchophylline Regulates the Circadian Rhythm of the Hypothalamus in Spontaneously Hypertensive Rats to Treat Hypertension

    Author: Wang, Danyang; Sun, Mengjia; Liu, Yuecheng; Wang, Lihua; Li, Chao; Li, Yunlun; Jiang, Haiqiang
    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 2, pp. 139-148. DOI: 10.2174/1381612829666221222115134
        PubMed      DOI
    6.Arginine-Glycine-Aspartic Acid-anchored Curcumin-based Nanotherapeutics Inhibit Pyroptosis-induced Cytokine Release Syndrome for In Vivo and In Vitro Sepsis Applications

    Author: Shi, Yi; Wu, Qian; Lu, Yi; Meng, Ling-Peng; Xu, Xiao-Ling; Wang, Xiao-Juan; Chen, Wei
    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 4, pp. 283-294. DOI: 10.2174/1381612829666230201144029
        PubMed      DOI
    7.Dysregulation of Angiopoietin-like-4 Associated with Hyperlipidemia-induced Renal Injury by AMPK/ACC Pathway

    Author: Qiu, WenHui; Huang, Luyang; Li, YueQiang; Liu, Qingquan; Lv, YongMan
    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 4, pp. 300-309. DOI: 10.2174/1381612829666221219123937
        PubMed      DOI
    8.Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease

    Author: Li, Lili; Zhang, Jiajia; Huang, Xiaoyue; Du, Jingguo; Tu, Zhiqiang; Wu, Haotian; Liu, Xu; Yuan, Mingqing
    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 2, pp. 95-115. DOI: 10.2174/1381612829666221216114912
        PubMed      DOI
    9.The Current Status of Antisense Gene Therapies for Bacteria-caused Diseases Challenges and Opportunities

    Author: Li, Jiawei; Liang, Xuejun; Wang, Fangxin; Wang, Juping; Ding, Feng
    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 4, pp. 272-282. DOI: 10.2174/1381612829666230118152428
        PubMed      DOI
    10.Soluble Urokinase Plasminogen Activator Receptor Contributes to ANCA-positive IgG-mediated Glomerular Endothelial Activation through TLR4 Pathway

    Author: Huang, Fei; Xu, Ranran; Wang, Yiru; Lv, Yongman; Liu, Qingquan
    Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 2, pp. 149-161. DOI: 10.2174/1381612829666221212094441
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Energy Material Advances013.80
    Journal of High Energy Astrophysics119.70
    VIEW012.60
    HARVARD BUSINESS REVIEW01.40
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE1086.90
    ACM Transactions on Intelligent Systems and Technology469.30
    Journal of the American Nutrition Association02.50
    TRANSACTIONS OF TIANJIN UNIVERSITY012.50
    Machine Intelligence Research06.70
    Molecular Biomedicine06.30
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共18


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室